(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)

Catalog No. :
ACYSVH518
CAS No. :
2828432-01-3
Molecular Formula :
C37H36N2O2
Molecular Weight :
540.71

IUPAC Name:(4R,4'R,5S,5'S)-2,2'-(cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)

(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$142.00Login to see priceInquiryInquiry
250mg97%$245.00Login to see priceInquiryInquiry
1g97%$706.00Login to see priceInquiryInquiry
5g97%$2047.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
IUPAC Name(4R,4'R,5S,5'S)-2,2'-(cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
MDL No.MFCD32201216
Molecular FormulaC37H36N2O2
Molecular Weight540.71
SMILESC1=CC=C([C@H]2N=C(C3(C4=N[C@H](C5=CC=CC=C5)[C@H](C5=CC=CC=C5)O4)CCCCCC3)O[C@H]2C2=CC=CC=C2)C=C1
InChI KeyJNZPQMLXKMPYDX-WZJLIZBTSA-N
SynonymOxazole, 2,2'-cycloheptylidenebis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-;(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
CAS No.2828432-01-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYSVH518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYSVH518 route product structure diagram
    ACYSVH5182828432-01-3
Inquiry

2. ACYSVH518 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYSVH518 route product structure diagram
    ACYSVH5182828432-01-3
Inquiry

Comments (0)